ANDOVER, Mass., July 28, 2021 /PRNewswire/ -- TransMedics
Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology
company that is transforming organ transplant therapy for patients
with end-stage lung, heart, and liver failure, today announced that
members of the management team will participate in a virtual
fireside chat at the upcoming Canaccord Genuity 41st
Annual Growth Conference. The fireside chat will take place on
Wednesday, August 11, 2021 at
4:30 p.m. Eastern Time.
Event: Canaccord Genuity 41st Annual Growth
Conference
Date: Wednesday, August
11, 2021
Time: 4:30 p.m. ET
A live and archived webcast of the fireside chat will be
available on the "Investors" section of the TransMedics website at
https://investors.transmedics.com/.
About TransMedics Group, Inc.
TransMedics is the
world's leader in portable extracorporeal warm perfusion and
assessment of donor organs for transplantation. Headquartered in
Andover, Massachusetts, the
company was founded to address the unmet need for more and better
organs for transplantation and has developed technologies to
preserve organ quality, assess organ viability prior to transplant,
and potentially increase the utilization of donor organs for the
treatment of end-stage heart, lung, and liver failure.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-canaccord-genuity-41st-annual-growth-conference-301343547.html
SOURCE TransMedics Group, Inc.